DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹11 Cr | ₹10 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr |
What is the latest Contingent Liabilities ratio of DR LAL PATHLABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹10 Cr |
How is Contingent Liabilities of DR LAL PATHLABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 4.99 | |
| Mar2024 | ₹10 Cr | -26.02 | |
| Mar2023 | ₹14 Cr | 3.43 | |
| Mar2022 | ₹13 Cr | 26.43 | |
| Mar2021 | ₹10 Cr | - | |
Compare Contingent Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹26,415.0 Cr | 2% | 0.9% | 6.9% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹112,343.0 Cr | -0.6% | 5% | 12.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹110,592.0 Cr | -4.4% | 6.4% | 15.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹76,900.0 Cr | -3.5% | 3.9% | 67.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,402.1 Cr | 1.7% | 4.4% | 46% | Stock Analytics | |
| GLOBAL HEALTH | ₹33,569.2 Cr | -9.2% | -6% | 17.9% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 2% |
0.9% |
6.9% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses